Global CRISPR And CRISPR-Associated (Cas) Genes Competitive Landscape Professional Research Report 2024

Global CRISPR And CRISPR-Associated (Cas) Genes Competitive Landscape Professional Research Report 2024

Research Summary

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and CRISPR-associated (Cas) genes are part of a bacterial and archaeal defense system against viruses and foreign genetic elements. CRISPR is a region in the bacterial genome containing short, repetitive sequences interspersed with unique spacer sequences derived from viral DNA. When a bacterium is infected by a virus, it captures a piece of the viral DNA and incorporates it into its CRISPR region. The CRISPR-associated (Cas) genes encode enzymes, such as Cas9, that use the spacer sequences as guides to identify and cleave specific viral DNA during subsequent infections, providing an adaptive immune response against the invading virus. In recent years, scientists have harnessed the CRISPR-Cas system as a powerful gene-editing tool for precise modification of DNA in various organisms, including plants, animals, and humans. The CRISPR-Cas technology has revolutionized biotechnology and genetic research, making it more accessible and efficient for applications like gene therapy, genetic engineering, and disease treatment. Its potential in various fields has led to significant advancements and opened up new possibilities in the realm of genetics and molecular biology.

According to DIResearch's in-depth investigation and research, the global CRISPR And CRISPR-Associated (Cas) Genes market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of CRISPR And CRISPR-Associated (Cas) Genes include Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, Intellia therapeutics, Cellectis, Horizon Discovery, Sigma Aldrich, Precision Biosciences, Genscript, Lonza Group Limited, Sangamo Biosciences, Integrated DNA Technologies, New England Biolabs, Origene Technologies etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of CRISPR And CRISPR-Associated (Cas) Genes. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global CRISPR And CRISPR-Associated (Cas) Genes market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the CRISPR And CRISPR-Associated (Cas) Genes market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of CRISPR And CRISPR-Associated (Cas) Genes industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of CRISPR And CRISPR-Associated (Cas) Genes Include:

Thermo Fisher Scientific

Editas Medicine

Caribou Biosciences

CRISPR therapeutics

Intellia therapeutics

Cellectis

Horizon Discovery

Sigma Aldrich

Precision Biosciences

Genscript

Lonza Group Limited

Sangamo Biosciences

Integrated DNA Technologies

New England Biolabs

Origene Technologies

CRISPR And CRISPR-Associated (Cas) Genes Product Segment Include:

Genome Editing

Genetic engineering

gRNA Database/Gene Librar

CRISPR Plasmid

Human Stem Cells

2.1.6 Genetically Modified Organisms/Crops

2.1.7 Cell Line Engineering

CRISPR And CRISPR-Associated (Cas) Genes Product Application Include:

Biotechnology Companies

Pharmaceutical Companies

Academic Institutes

Research and Development Institutes

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global CRISPR And CRISPR-Associated (Cas) Genes Industry PESTEL Analysis

Chapter 3: Global CRISPR And CRISPR-Associated (Cas) Genes Industry Porter’s Five Forces Analysis

Chapter 4: Global CRISPR And CRISPR-Associated (Cas) Genes Major Regional Market Size and Forecast Analysis

Chapter 5: Global CRISPR And CRISPR-Associated (Cas) Genes Market Size and Forecast by Type and Application Analysis

Chapter 6: North America CRISPR And CRISPR-Associated (Cas) Genes Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe CRISPR And CRISPR-Associated (Cas) Genes Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China CRISPR And CRISPR-Associated (Cas) Genes Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) CRISPR And CRISPR-Associated (Cas) Genes Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America CRISPR And CRISPR-Associated (Cas) Genes Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global CRISPR And CRISPR-Associated (Cas) Genes Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources